News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Catalent Pharma Solutions Sees IPO Of 42.5 Million Shares Priced Between $19-$22/Share


7/21/2014 6:09:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Catalent, a global provider of oral, injectable and respiratory drug delivery technologies, announced terms for its IPO on Friday. The Somerset, NJ-based company plans to raise $871 million by offering 42.5 million shares at a price range of $19 to $22. At the midpoint of the proposed range, Catalent would command a fully diluted market value of $2.5 billion.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at Reuters
Read at Outsourcing-Pharma.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES